EUVIMEDEUVIMED entdecken
Crossref

Discovery of pyrrolo[2,3-d]pyrimidine derivatives with inhibitory effect on liver cancer stem cell

Xuecong Zhang, Xuechun Chen, Liwei Wang, Yiyuan Chang, Jiaxin Li, Jijian Yang, Dongxuan Ni, Ruihan Zhang, Rong Liu, Weilie Xiao

Medicinal Chemistry Research · 2026

DOI: 10.1007/s00044-026-03586-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinal Chemistry Research, 2026. Verfasst von Xuecong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource of Ministry of Education, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Yun…. Hauptthemen laut MEDLINE: Pyrimidines, Neoplastic Stem Cells, Liver Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Applied Basic Research Foundation of Yunnan Province, Project of Yunnan Characteristic Plant Screening and R&D Service CXO Platform.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide. The malignancy of HCC is closely linked to liver cancer stem cells (CSCs), making the application of anti-CSC drugs a promising therapeutic approach. In this study, we report the discovery of novel pyrrolo[2,3-d]pyrimidine derivatives as potent inhibitors of liver CSC. Structural optimization and anti-CSC screening led to the identification of improved compounds 6i , 6j , and 7e , which significantly inhibited Huh7 sphere formation while exhibiting low toxicity to standard 2D-cultured tumor cells. Notably, compound 6i sensitizes both parental and Lenvatinib-resistant HCC cells to Lenvatinib treatment, showing a synergistic interaction. Collectively, these findings establish the pyrrolo[2,3-d]pyrimidine as a promising scaffold for targeting liver CSC and provide a potential combination strategy to overcome Lenvatinib resistance in advanced HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesNeoplastic Stem CellsLiver NeoplasmsAntineoplastic AgentsPyrrolesCarcinoma, HepatocellularDrug DiscoveryHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationCell Line, TumorMolecular StructureQuinolinesDose-Response Relationship, Drug

Stichwörter der Autor:innen

Combination therapyHepatocellular carcinomaLiver cancer stem cellsPyrrolo[2,3-d]pyrimidine derivatives

Substanzen

PyrimidinesAntineoplastic AgentsPyrrolesPyrrolo(2,3-d)pyrimidineQuinolines

Autor:innen und Institutionen

  • Key Laboratory of Medicinal Chemistry for Natural Resource of Ministry of Education, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Yunnan Research & Development Center for Natural Products, School of Phar…
  • Translational Cancer Research Center, Peking University First Hospital, Beijing, China.
  • College of Integrated Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • International Cancer Institute, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Translational Cancer Research Center, Peking University First Hospital, Beijing, China. liurong@bjmu.edu.cn.
  • Southwest United Graduate School, 650092, Kunming, China. liurong@bjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Applied Basic Research Foundation of Yunnan Province
  • Project of Yunnan Characteristic Plant Screening and R&D Service CXO Platform

Zitieren

APA

Zhang, X., Chen, X., Wang, L., Chang, Y., Li, J., Yang, J., Ni, D., Zhang, R., Liu, R., & Xiao, W. (2026). Discovery of pyrrolo[2,3-d]pyrimidine derivatives with inhibitory effect on liver cancer stem cell. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03586-7

Vancouver

Zhang X, Chen X, Wang L, Chang Y, Li J, Yang J, et al. Discovery of pyrrolo[2,3-d]pyrimidine derivatives with inhibitory effect on liver cancer stem cell. Medicinal Chemistry Research. 2026. doi:10.1007/s00044-026-03586-7

BibTeX
@article{Zhang2026,
  author = {Zhang, Xuecong and Chen, Xuechun and Wang, Liwei and Chang, Yiyuan and Li, Jiaxin and Yang, Jijian and Ni, Dongxuan and Zhang, Ruihan and Liu, Rong and Xiao, Weilie},
  title = {Discovery of pyrrolo[2,3-d]pyrimidine derivatives with inhibitory effect on liver cancer stem cell},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  doi = {10.1007/s00044-026-03586-7}
}
Kostenlos starten →